Total Payments
$5,466
2024 Payments
$112.25
Companies
33
Transactions
341
Medicare Patients
5,283
Medicare Billing
$459,909
Payment Breakdown by Category
Food & Beverage$5,396 (98.7%)
Other$45.00 (0.8%)
Education$25.10 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,396 | 338 | 98.7% |
| Debt forgiveness | $45.00 | 1 | 0.8% |
| Education | $25.10 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $852.91 | 63 | $0 (2019) |
| Amgen Inc. | $846.89 | 46 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $465.41 | 28 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $322.93 | 28 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $316.01 | 21 | $0 (2019) |
| Gilead Sciences, Inc. | $287.96 | 24 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $259.76 | 16 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $188.41 | 7 | $0 (2018) |
| Astellas Pharma US Inc | $176.04 | 10 | $0 (2019) |
| Abbott Laboratories | $163.93 | 10 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $112.25 | 4 | Medtronic, Inc. ($66.75) |
| 2023 | $24.30 | 1 | SANOFI-AVENTIS U.S. LLC ($24.30) |
| 2022 | $66.70 | 2 | Baxter Healthcare ($45.00) |
| 2020 | $65.45 | 1 | Biosense Webster, Inc. ($65.45) |
| 2019 | $1,295 | 76 | Amgen Inc. ($220.03) |
| 2018 | $2,045 | 131 | Janssen Pharmaceuticals, Inc ($379.10) |
| 2017 | $1,857 | 126 | Amgen Inc. ($331.71) |
All Payment Transactions
341 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 05/02/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $45.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/07/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 01/12/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $35.31 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 05/10/2023 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/08/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Education | In-kind items and services | $21.70 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/06/2022 | Baxter Healthcare | — | Debt forgiveness | In-kind items and services | $45.00 | General |
| 01/08/2020 | Biosense Webster, Inc. | Carto 3 System (Device) | Food and Beverage | In-kind items and services | $65.45 | General |
| Category: Cardiology | ||||||
| 08/23/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/21/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Cardiology | ||||||
| 08/16/2019 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Cardiology | ||||||
| 08/14/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/13/2019 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/08/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/07/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Hypertriglyceridemia | ||||||
| 08/07/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $4.45 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/05/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.69 | General |
| Category: Cardiovascular | ||||||
| 08/02/2019 | Smith+Nephew, Inc. | Santyl (Drug), REGRANEX | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Pharma Product | ||||||
| 07/30/2019 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Cardiology | ||||||
| 07/29/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Hypertriglyceridemia | ||||||
| 07/26/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/24/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/22/2019 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 07/17/2019 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/12/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.53 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,128 | 1,543 | $362,199 | $86,423 |
| 2022 | 19 | 1,190 | 1,738 | $360,447 | $97,566 |
| 2021 | 18 | 1,434 | 2,230 | $489,127 | $140,328 |
| 2020 | 22 | 1,531 | 2,382 | $520,538 | $135,593 |
Total Patients
5,283
Total Services
7,893
Medicare Billing
$459,909
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 382 | 475 | $135,740 | $39,518 | 29.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 126 | 128 | $77,952 | $17,828 | 22.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 15 | 15 | $17,550 | $4,753 | 27.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 43 | 43 | $17,200 | $4,440 | 25.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 302 | 356 | $23,140 | $3,459 | 14.9% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 16 | 32 | $19,040 | $3,061 | 16.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 55 | 55 | $33,495 | $2,886 | 8.6% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 14 | 56 | $6,720 | $2,629 | 39.1% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 11 | 11 | $6,985 | $1,946 | 27.9% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 20 | 202 | $6,060 | $1,594 | 26.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 21 | $3,780 | $1,271 | 33.6% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 16 | 16 | $4,000 | $760.49 | 19.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 14 | $2,820 | $721.94 | 25.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 58 | 74 | $1,244 | $621.60 | 50.0% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 11 | 11 | $2,299 | $424.16 | 18.4% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 11 | 12 | $720.00 | $215.64 | 30.0% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 11 | 11 | $3,069 | $195.80 | 6.4% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 11 | 11 | $385.00 | $97.29 | 25.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 397 | 489 | $133,415 | $42,194 | 31.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 144 | 146 | $88,914 | $21,351 | 24.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 60 | 60 | $24,000 | $7,053 | 29.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 17 | 17 | $19,890 | $5,555 | 27.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 322 | 378 | $24,570 | $3,822 | 15.6% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2022 | 17 | 34 | $16,230 | $3,387 | 20.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 15 | 60 | $7,200 | $2,908 | 40.4% |
About Dr. Mark Charlamb, MD
Dr. Mark Charlamb, MD is a Cardiovascular Disease healthcare provider based in Fayetteville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1760480982.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Charlamb, MD has received a total of $5,466 in payments from pharmaceutical and medical device companies, with $112.25 received in 2024. These payments were reported across 341 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($5,396).
As a Medicare-enrolled provider, Charlamb has provided services to 5,283 Medicare beneficiaries, totaling 7,893 services with total Medicare billing of $459,909. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Fayetteville, NY
- Active Since 07/12/2005
- Last Updated 10/01/2019
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1760480982
Products in Payments
- XARELTO (Drug) $852.91
- Corlanor (Drug) $741.23
- ENTRESTO (Drug) $322.93
- PRADAXA (Drug) $316.01
- PRALUENT (Drug) $259.25
- MULTAQ (Drug) $206.16
- PRALUENT ALIROCUMAB INJECTION (Biological) $194.70
- BRILINTA (Drug) $185.29
- LifeVest (Device) $152.83
- Adempas (Drug) $149.04
- ELIQUIS (Drug) $147.77
- BYSTOLIC (Drug) $139.69
- Impella (Device) $120.73
- Definity (Drug) $110.89
- LEXISCAN (Drug) $106.60
- Repatha (Biological) $105.66
- Amplia MRI (Device) $97.17
- Vascepa (Drug) $93.49
- Lexiscan (Drug) $69.44
- LINQ II (Device) $66.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Fayetteville
Andrew Darlington, Do, DO
Cardiovascular Disease — Payments: $1.0M
Cardiovascular Disease $1.0M
Frank Fedele, Md, MD
Cardiovascular Disease — Payments: $27,524
Cardiovascular Disease $27,524
Yang Yang
Cardiovascular Disease — Payments: $20,941
Cardiovascular Disease $20,941
Dr. Shaun Senter, Md, MD
Cardiovascular Disease — Payments: $16,513
Cardiovascular Disease $16,513
Dr. Michael Miller, Md, MD
Cardiovascular Disease — Payments: $15,493
Cardiovascular Disease $15,493
Sirisha Reddy, Md, MD
Cardiovascular Disease — Payments: $10,475
Cardiovascular Disease $10,475